《Stem Cell Reviews And Reports》重点专注发布CELL & TISSUE ENGINEERING-CELL BIOLOGY领域的新研究，旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。该杂志创刊至今，在CELL & TISSUE ENGINEERING-CELL BIOLOGY领域，有较高影响力，对来稿文章质量要求较高，稿件投稿过审难度较大。欢迎广大同领域研究者投稿该杂志。
| CiteScore | SJR | SNIP | CiteScore排名 | |||
|---|---|---|---|---|---|---|
| 9.3 | 1.19 | 0.843 | 学科类别 | 分区 | 排名 | 百分位 |
|
大类：大类：Biochemistry,GeneticsandMolecularBiology
小类：小类：CellBiology
|
Q2 | 72/285 | 74% | |||
|
大类：大类：Biochemistry,GeneticsandMolecularBiology
小类：小类：CancerResearch
|
Q2 | 59/230 | 74% | |||
| 按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：CELL & TISSUE ENGINEERING | SCIE | Q2 | 10 / 31 | 69.4% |
| 学科：CELL BIOLOGY | SCIE | Q2 | 72 / 205 | 65.1% |
| 学科：MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | 52 / 189 | 72.8% |
| 按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：CELL & TISSUE ENGINEERING | SCIE | Q2 | 10 / 31 | 69.35% |
| 学科：CELL BIOLOGY | SCIE | Q2 | 63 / 205 | 69.51% |
| 学科：MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | 49 / 189 | 74.34% |
文章名称
引用次数
circRNA Expression Profiles in Human Bone Marrow Stem Cells Undergoing Osteoblast Differentiation
28
Cell Cycle Regulation of Stem Cells by MicroRNAs
28
Dysfunction of Mesenchymal Stem Cells Isolated from Metabolic Syndrome and Type 2 Diabetic Patients as Result of Oxidative Stress and Autophagy may Limit Their Potential Therapeutic Use
27
Expression of Cancer Stem Cell Biomarkers in Human Head and Neck Carcinomas: a Systematic Review
21
Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9
20
Mesenchymal Stem Cells on Horizon: A New Arsenal of Therapeutic Agents
18
Pluripotent Stem Cells for Retinal Tissue Engineering: Current Status and Future Prospects
17
Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects
17
Biological Products: Cellular Therapy and FDA Approved Products
17
Solid Tumors Challenges and New Insights of CAR T Cell Engineering
16
国家/地区
发文量
TUSA
93
TCHINA MAINLAND
52
TPoland
33
TIndia
32
TBrazil
25
TIran
22
TGERMANY (FED REP GER)
21
TItaly
17
TFrance
16
TJapan
10
